Johnson & Johnson names Gorsky new chairman
Johnson & Johnson (NYSE:JNJ) named CEO Alex Gorsky chairman of its board of directors, effective December 28. Gorsky replaces current chairman Bill Weldon, who will retire from the company in the 1st quarter of 2013.
Gorsky joined JNJ in 1988 and was named company group chairman of Johnson & Johnson’s pharmaceuticals business in Europe, the Middle East and Africa in 2003. He left the company briefly and returned in 2008 as group chairman for Ethicon. He was named CEO of the New Brunswick, NJ-medical device giant in February.
"I am truly honored to succeed Bill Weldon as chairman of Johnson & Johnson," Gorsky said in prepared remarks. "Bill’s leadership and contributions to Johnson & Johnson over a 41-year career leave us well-positioned to continue addressing the world’s most prevalent diseases and unmet needs in health care. Our financial strength, global reach, and innovations that help people live longer, healthier lives are a proud legacy for Bill and a strong foundation for the future of Johnson & Johnson."
In a seperate release, J&J also added Dr. A. Eugene Washington to its board of directors.
Washington currently serves as vice chancellor of health sciences, dean of school of medicine at University of California, Los Angeles, and CEO of the UCLA health system. Washington is also a professor of gynecology and health policy at UCLA, according to regulatory filing.
Read more
Tissue Regenix named new U.S. subsidiary president
York, England-based regenerative medicine company Tissue Regenix named Greg Bila as president of the company’s new U.S. subsidiary.
Bila most recently work at Kinetic Concepts and has 20 years experience in pharmaceutical and medical device fields.
Read more
BED Medical CFO leaves
BED Medical CFO Dennis Gauger stepped down from his role as the company’s CFO, effective Dec. 31, 2012. He has held the position for 5 years.
Gauger will be the company’s consultant during the transition period with not more than 10 hours of consulting services each week through June 30, 2013 at $100 per hour, according to a regulatory filing.
Read more
Electromed names new CEO
Electromed named Kathleen Skarvan CEO of the company, effective December 1, 2012. Skarvan will succeed Dr. James Cassidy, COO of the company who has been the company’s interim CEO since May 2012.
Skarvan will recieve $210,000 annual salary, plus bonus up to 20% of her base salary.
Skarvan most recently is VP of operations at OEM Fabricators, prior to which, she worked in various roles at Hutchinson Technology.
Two obstetricians to lead GOP doctors caucus
Two obstetricians, Rep. Phil Roe (R-Tenn.) and Rep. Phil Gingrey (R-GA), who oppose the Patient Protection and Affordable Care Act, will lead the House’s GOP doctors caucus.
Roe currently sits as vice chairman of 21 healthcare providers. Gingrey co-founded the caucus in 2009 with Rep. Tim Murphy (R-PA). Roe will succeed Murphy, who will resign from his role to focus on his responsibilities as the new chairman of the House Energy and Commerce Oversight and Investigations Subcommittee.
Read more
Orthofix International adds 1 to its board
Boston-based medical device maker Orthofix International added Maria Sainz to its board of directors.
Sainz currently is president, CEO and director of CardioKinetix. She was president & CEO of Concentric Medical and became general manager of the business unit of Stryker (NYSE:SYK) Neurovascular after Concentric Medical was acquired by Stryker Neurovascular in 2011. She also worked at Guidant,which was aquired by Boston Scientific (NYSE:BSX).
Read more
Histogenics welcomes new board director
Histogenics named Kevin Rakin to its board of directors.
Most recently, Rakin was president of Regenerative Medicine at Shire (NSDQ:SHPGY) , pior to which, he was chairman & CEO of Advanced BioHealing. Shire bought ABH for $750 million in 2011. Rakin also was a co-founder, president and CEO of Genaissance Pharmaceuticals.
Read more
Tenaxis Medical adds 1 board director
Tenaxis Medical added Dr. William Cohn to its board of directors.
Cohn is a cardiovascular surgeon and the director of minimally invasive surgical technology at the Texas Heart Institute in Houston, Texas. He is also co-director of the Cullen Cardiovascular Research Laboratory, associate professor of surgery at Baylor College of Medicine and adjunct professor of Bioengineering at the University of Houston.
Read more
Iridex’s board director resigns
Iridex’s board director Dominik Beck resigned from his position on the board of directors and received $193,084 from the company.
Beck was named as Iridex’s president & CEO last year. He was president & COO at Haag-Streit U.S. Holdings, a U.S. subsidiary of Switzerland-based Haag-Streit International
Read more